Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]

PALOP School of Oncology

Prof Lúcio Lara Santos - Instituto Português De Oncologia, Lison, Portugal

PALOP School of Oncology ( Prof Lúcio Lara Santos - Instituto Português De Oncologia, Lison, Portugal )

Essential surgical management for gynaecological cancers

Dr Rahel Ghebre - University of Rwanda, Kigali, Rwanda and University of...

Essential surgical management for gynaecological cancers ( Dr Rahel Ghebre - University of Rwanda, Kigali, Rwanda and University of Minnesota, USA )

Adoptive cell therapy for solid tumours

Dr Sophie Papa - Guy's Hospital, London, UK

Adoptive cell therapy for solid tumours ( Dr Sophie Papa - Guy's Hospital, London, UK )

Managing cytokine release syndrome

Dr Charlotte Graham - King’s College London, London, UK

Managing cytokine release syndrome ( Dr Charlotte Graham - King’s College London, London, UK )

Checkpoint inhibition in practice and in public

Dr Christy Ralph - St. James's Institute of Oncology, Leeds, UK

Checkpoint inhibition in practice and in public ( Dr Christy Ralph - St. James's Institute of Oncology, Leeds, UK )

Combination immunotherapies and multi-modal treatment

Dr Paul Nathan - Mount Vernon Hospital, Northwood, UK

Combination immunotherapies and multi-modal treatment ( Dr Paul Nathan - Mount Vernon Hospital, Northwood, UK )

The next steps for effective cancer immunotherapy and viral vaccines

Prof Peter Selby - St James University Hospital, Leeds, UK

The next steps for effective cancer immunotherapy and viral vaccines ( Prof Peter Selby - St James University Hospital, Leeds, UK )

Multiorgan toxicity following combination immunotherapy treatment in melanoma

Dr Lewis Au - Royal Marsden Hospital, London, UK

Multiorgan toxicity following combination immunotherapy treatment in melanoma ( Dr Lewis Au - Royal Marsden Hospital, London, UK )

Can we afford immunotherapy?

Dr Peter Hall - University of Edinburgh, Edinburgh, UK

Can we afford immunotherapy? ( Dr Peter Hall - University of Edinburgh, Edinburgh, UK )

Predicting response to immunotherapy

Prof Christian Ottensmeier - Southampton Royal Hospital, UK

Predicting response to immunotherapy ( Prof Christian Ottensmeier - Southampton Royal Hospital, UK )

Improving access to pathology in low resource settings

Dr Abeer Shaaban - University of Birmingham, Birmingham, UK

Improving access to pathology in low resource settings ( Dr Abeer Shaaban - University of Birmingham, Birmingham, UK )

Pathology access and advocacy

Dr Kenneth Fleming - National Cancer Institute, Washington, USA

Pathology access and advocacy ( Dr Kenneth Fleming - National Cancer Institute, Washington, USA )

More from ecancer